Treanda and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Treanda (bendamustine hydrochloride) and Ondansetron (ondansetron). Common drug interactions include platelet count decreased among females and tumour lysis syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Treanda and Ondansetron. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.

What is Treanda?

Treanda has active ingredients of bendamustine hydrochloride. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 4,411 Treanda users. Check the latest studies of Treanda.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

On Jul, 07, 2026

98 people who take Treanda and Ondansetron together, and have interactions are studied.

Treanda and Ondansetron drug interactions.

What are the common drug interactions of Treanda and Ondansetron, by gender? *:

female:

Platelet count decreased
White blood cell count decreased
Pyrexia (fever)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Constipation
Hypokalaemia (low potassium)
Infusion site pain
International normalised ratio increased
Renal failure acute (rapid kidney dysfunction)
Weight fluctuation

male:

Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Diarrhoea
Hyperkalaemia (damage to or disease of the kidney)
Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
Hypotension (abnormally low blood pressure)
Pleural effusion (water on the lungs)
Renal tubular necrosis (death of kidney tubules)
Skin toxicity (skin damage due to toxin/poison)
Toxic skin eruption (skin breakdown due to toxic substance)

What are the common drug interactions of Treanda and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Renal impairment (severely reduced kidney function)

20-29:

Pyelonephritis (inflammation of kidney caused by bacteria)

30-39:

n/a

40-49:

Constipation
Infusion site haematoma (localized swelling filled with blood at infusion site)
Infusion site phlebitis (inflammation of the walls of a vein at infusion site)
Infusion site reaction
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Chills (felling of cold)
Dehydration (dryness resulting from the removal of water)
Dizziness
Headache (pain in head)
Hyperkalaemia (damage to or disease of the kidney)
Infusion related reaction
Neutropenia (an abnormally low number of neutrophils)
Pleural effusion (water on the lungs)

60+:

Hypotension (abnormally low blood pressure)
Renal failure acute (rapid kidney dysfunction)
Toxic skin eruption (skin breakdown due to toxic substance)
Hypokalaemia (low potassium)
Chills (felling of cold)
Fatigue (feeling of tiredness)
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Lymphocyte count decreased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 19 people, 19.39%
Burkitt Lymphoma (cancer of the lymphatic system): 14 people, 14.29%
Stress And Anxiety: 11 people, 11.22%
High Blood Pressure: 11 people, 11.22%
Pain: 10 people, 10.20%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 7 people, 7.14%
Insomnia (sleeplessness): 6 people, 6.12%
Diarrhea: 5 people, 5.10%
Constipation: 5 people, 5.10%

* Approximation only. Some reports may have incomplete information.

Do you take Treanda and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously